Routes of Administration
Routes of administration determine how drugs, fluids, vaccines and biologics reach target tissues—IV/IO, IM/SC, oral, intranasal, inhalation, transdermal and implantable systems. Route choice governs onset, bioavailability, stability, infection risk and logistical footprint; optimizing administration enables faster hemorrhage resuscitation, effective prophylaxis, and sustained therapy in prolonged-field care.
Technical Challenges
Delayed vascular access in polytrauma, crush and hypovolemic shock
Medication stability and cold-chain limitations in austere environments
Variable bioavailability and unpredictable absorption (oral, transdermal, intranasal)
Infection risk and biofilm formation at indwelling delivery sites
Limited patient-compliant or minimally trained administration options under stress
Emerging Opportunities
Rapid, reliable non-IV alternatives that match IV onset and bioavailability
Compact, ruggedized delivery systems with extended shelf life without cold chain
Field-suitable formulations for mass prophylaxis and inhaled/IN vaccines
Low-skill devices for prolonged-field care and delayed evacuation scenarios
Current and Emerging Technologies in Routes of Administration
Intravenous (IV) and Intraosseous (IO) access
Gold-standard for resuscitation and rapid drug delivery. IO provides emergent access when peripheral IV fails; innovations focus on faster placement, antimicrobial coatings, and miniaturized fluid warmers.
Intramuscular (IM) and Subcutaneous (SC) injections
Widely used for vaccines and depot therapeutics. Research targets auto-injectors, microarray/needle-free devices, and long-acting depot formulations to extend protection with single-dose administration.
Intranasal and inhalation delivery
Mucosal routes enable needle-free, rapid systemic or local action (e.g., naloxone, influenza vaccines). Advances include absorption enhancers, dry-powder inhalers, and aerosolized biologics for mass administration.
Oral and enteral formulations
Preferred for logistics and compliance but limited by GI absorption and first-pass metabolism. Innovations target prodrugs, mucoadhesive systems, and enteral feeds compatible with field nutrition and analgesia.
Transdermal and topical systems
Patches, microneedle arrays and topical formulations offer sustained release and simplified administration. Emerging work improves permeability, temperature stability, and dosing precision for vaccines and analgesics.
Implantable pumps and long-acting depots
Reservoirs, implanted ports and osmotic pumps support chronic or prolonged-field therapies. Focus areas include refillable, antimicrobial, and remotely programmable devices for extended physiologic support.
Combination technologies and formulation science
Nanocarriers, stabilizing excipients, adjuvants and smart-release matrices are being integrated to improve stability, target specificity and dose sparing—critical where logistics constrain supply.
Importance to Military Medicine
Life-saving timeliness
Faster onset routes and reliable alternatives to IV/IO reduce morbidity and mortality in hemorrhage, shock and airway emergencies.
Prolonged and distributed care
Field-stable, easy-to-use delivery systems enable hours-to-days of care when evacuation is delayed or resources are limited.
Operational logistics and readiness
Reduced cold-chain needs, compact devices and simplified administration lower logistic burden and increase force readiness.
Mass prophylaxis and force health protection
Needle-free and rapid-delivery options facilitate rapid immunization and chemoprophylaxis during outbreaks or biothreat events.
Alignment with the MTEC Mission
Directly advances MTEC’s DoD-focused mission by accelerating development of field-relevant delivery technologies that translate rapidly to operational use.
Supports cross-disciplinary projects spanning trauma care, infectious disease countermeasures, and prolonged care—areas within MTEC’s portfolio.
Emphasizes rapid transition to real-world use: ruggedized devices, stability-enhanced formulations and low-skill deployment tools that meet DoD timelines.
Enables dual-use impact—civilian emergency medicine and public health benefit from military-driven advances, consistent with MTEC’s translational goals.
Dual-Use (Military + Civilian) Applications
Emergency and prehospital care: needle-free naloxone, inhaled analgesics and rapid IM/auto-injectors for first responders and clinicians.
Public health and mass vaccination: stable, easy-to-administer formulations (dry-powder, microneedles) for rapid immunization without cold chain.
Chronic disease management: implantable or long-acting systems developed for austere care can improve adherence in civilian remote and underserved settings.
Disaster response and biodefense: compact, user-friendly delivery platforms expedite mass prophylaxis and therapeutics during outbreaks or exposures.
Explore MTEC Members with Routes of Administration Capabilities
MTEC members combine clinical trauma expertise, formulation science, device engineering and field testing to de-risk route-of-administration solutions. Consortium strengths include access to DoD clinical testbeds, rapid prototyping, regulatory strategy support and partnerships that accelerate translation from bench to battlefield.
Explore member profiles to discover innovators in IO/IV devices, microneedles, inhaled biologics, thermal-stable formulations and deployable administration systems—partners poised to advance military and civilian care.
118 Members with Routes of Administration capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I³R) at the University of Arkansas is dedicated to pioneering solutions to wicked problems and societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I³R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Action Medical Technologies is a pharmaceutical and medical device company focused on developing innovative solutions that integrate medications with advanced devices and injector systems to improve patient outcomes, particularly in austere prehospital environments.
Revolution Biomanufacturing Inc. (RBIx) is expanding beyond traditional CDMO Process/Analytical Development and Manufacturing services to pioneer distributed molecular manufacturing. A new class of digital biomanufacturing that enables the autonomous design, manufacture, quality verification, and deployment of Nucleic Acid therapeutics and molecular diagnostics at the point of need. By integrating AI-driven sequence optimization, enzymatic nucleic acid synthesis, Nanoparticle design and manufacturing (LNP & EV), closed-loop quality control, and field-deployable manufacturing platforms, RBIx is creating adaptive biological infrastructure capable of responding to emerging diseases, national security threats, and personalized medicine with unprecedented speed and flexibility.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
Evimero is an interdisciplinary company focused on understanding the interactions between microorganisms and human health, agriculture, and the environment, utilizing Systems Biology and AI/ML. Evimero applies molecular principles to infectious disease and microbiome science to improve health outcomes and environmental sustainability through targeted interventions in dysbiotic microbiomes and in people with infectious disorders. Evimero has an infectious disease product pipeline including both prophylactic and diagnostic assets against common causes of Travelers' Diarrhea, including a unique approach to preventing infection with human Norovirus, enterotoxigenic E. coli (ETEC) and others. Evimero's pipeline of drugs targeting human and animal microbiomes includes early-stage assets aimed at generalized microbiome-driven inflammation and gut leak, and specific disease-targeted disorders including Parkinson Disease and Inflammatory Bowel Diseases. Evimero's platform also makes possible a suite of point-of-care diagnostics that can be used for patient cohorting (infectious diseases), risk stratification, and ultimately informing therapeutic decision-making. The nature of Evimero's platform assures a steady stream of novel assets targeting both infectious diseases and chronic disorders with roots in microbiome dysfunction.
Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.
Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.